Jaffee EM - Search Results

1

Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer.

Couch ME, Ferris RL, Brennan JA, Koch WM, Jaffee EM, Leibowitz MS, Nepom GT, Erlich HA, Sidransky D. Couch ME, et al. Among authors: jaffee em. Clin Cancer Res. 2007 Dec 1;13(23):7199-206. doi: 10.1158/1078-0432.CCR-07-0682. Clin Cancer Res. 2007. PMID: 18056201

2

Genetically engineered tumor cell vaccine in a head and neck cancer model.

Couch M, Saunders JK, O'Malley BW Jr, Pardoll D, Jaffee E. Couch M, et al. Laryngoscope. 2003 Mar;113(3):552-6. doi: 10.1097/00005537-200303000-00029. Laryngoscope. 2003. PMID: 12616213

3

Spatial distribution of tumor vaccine improves efficacy.

Couch M, Saunders JK, O'Malley BW Jr, Pardoll D, Jaffee E. Couch M, et al. Laryngoscope. 2003 Aug;113(8):1401-5. doi: 10.1097/00005537-200308000-00026. Laryngoscope. 2003. PMID: 12897566

4

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.

Ferris RL, Jaffee EM, Ferrone S. Ferris RL, et al. Among authors: jaffee em. J Clin Oncol. 2010 Oct 1;28(28):4390-9. doi: 10.1200/JCO.2009.27.6360. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697078 Free PMC article. Review.

5

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Argani P, et al. Clin Cancer Res. 2001 Dec;7(12):3862-8. Clin Cancer Res. 2001. PMID: 11751476

6

Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.

Zhou X, Jun DY, Thomas AM, Huang X, Huang LQ, Mautner J, Mo W, Robbins PF, Pardoll DM, Jaffee EM. Zhou X, et al. Among authors: jaffee em. Cancer Res. 2005 Feb 1;65(3):1079-88. Cancer Res. 2005. PMID: 15705910

7

Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice.

Moran TP, Burgents JE, Long B, Ferrer I, Jaffee EM, Tisch RM, Johnston RE, Serody JS. Moran TP, et al. Among authors: jaffee em. Vaccine. 2007 Sep 4;25(36):6604-12. doi: 10.1016/j.vaccine.2007.06.058. Epub 2007 Jul 17. Vaccine. 2007. PMID: 17675184 Free PMC article.

8

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RH. Blackford A, et al. Among authors: jaffee em. Clin Cancer Res. 2009 Jul 15;15(14):4674-9. doi: 10.1158/1078-0432.CCR-09-0227. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584151 Free PMC article.

9

Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.

Blair AB, Kim VM, Muth ST, Saung MT, Lokker N, Blouw B, Armstrong TD, Jaffee EM, Tsujikawa T, Coussens LM, He J, Burkhart RA, Wolfgang CL, Zheng L. Blair AB, et al. Among authors: jaffee em. Clin Cancer Res. 2019 Sep 1;25(17):5351-5363. doi: 10.1158/1078-0432.CCR-18-4192. Epub 2019 Jun 11. Clin Cancer Res. 2019. PMID: 31186314 Free PMC article.

10

Cancer vaccines.

Greten TF, Jaffee EM. Greten TF, et al. Among authors: jaffee em. J Clin Oncol. 1999 Mar;17(3):1047-60. doi: 10.1200/JCO.1999.17.3.1047. J Clin Oncol. 1999. PMID: 10071300 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

328 results

Search Page